Skip to main content

Relmada Therapeutics, Inc.

RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553643

In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Relmada Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
134
+21 vs. Q2 2022
Shares held
25.8M
+1.10M (+4.4%) vs. Q2 2022
Total value
$953.6M
+$485.2M (+103.6%) vs. Q2 2022
New holders
33
46 more added
Sold out
12
34 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RLMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 134 institutions
Q1 2021: 82 institutionsQ2 2021: 85 institutionsQ3 2021: 87 institutionsQ4 2021: 97 institutionsQ1 2022: 113 institutionsQ2 2022: 113 institutionsQ3 2022: 134 institutionsQ4 2022: 110 institutionsQ1 2023: 91 institutionsQ2 2023: 95 institutionsQ3 2023: 88 institutionsQ4 2023: 83 institutionsQ1 2024: 93 institutionsQ2 2024: 79 institutionsQ3 2024: 69 institutionsQ4 2024: 48 institutionsQ1 2025: 44 institutionsQ2 2025: 50 institutionsQ3 2025: 44 institutionsQ4 2025: 78 institutionsQ1 2026: 103 institutionsQ2 2026: 126 institutions
Value heldQ3 2022: $953.6M
Q1 2021: $335.7MQ2 2021: $318.3MQ3 2021: $262.8MQ4 2021: $467.2MQ1 2022: $623.1MQ2 2022: $468.5MQ3 2022: $953.6MQ4 2022: $66.8MQ1 2023: $40.3MQ2 2023: $39.7MQ3 2023: $45.0MQ4 2023: $56.4MQ1 2024: $66.5MQ2 2024: $40.7MQ3 2024: $40.2MQ4 2024: $4.36MQ1 2025: $1.68MQ2 2025: $3.18MQ3 2025: $15.5MQ4 2025: $245.8MQ1 2026: $588.8MQ2 2026: $693.7M
Institutions holding RLMD and their total value by quarter
QuarterHoldersValue
Q2 2026126$693.7M
Q1 2026103$588.8M
Q4 202578$245.8M
Q3 202544$15.5M
Q2 202550$3.18M
Q1 202544$1.68M
Q4 202448$4.36M
Q3 202469$40.2M
Q2 202479$40.7M
Q1 202493$66.5M
Q4 202383$56.4M
Q3 202388$45.0M
Q2 202395$39.7M
Q1 202391$40.3M
Q4 2022110$66.8M
Q3 2022134$953.6M
Q2 2022113$468.5M
Q1 2022113$623.1M
Q4 202197$467.2M
Q3 202187$262.8M
Q2 202185$318.3M
Q1 202182$335.7M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Relmada Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding RLMD in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
apricus wealth, LLC107,329$3.97M3.95%+73,995+222.0%Added
Invesco Ltd.114,245$4.23M0.00%+103,578+971.0%Added
Schonfeld Strategic Advisors LLC150,500$5.57M0.05%+150,500New
Candriam Luxembourg S.C.A.174,605$6.46M0.05%+32,419+22.8%Added
Sphera Funds Management Ltd.193,230$7.15M1.27%−273,600−58.6%Reduced
Price T Rowe Associates Inc196,556$7.28M0.00%+27,799+16.5%Added
Dimensional Fund Advisors LP198,900$7.36M0.00%−2,707−1.3%Reduced
Bank of New York Mellon Corp214,876$7.96M0.00%−27,143−11.2%Reduced
Cowen and Company, LLC216,441$8.01M0.77%−850,413−79.7%Reduced
Deutsche Bank AG237,306$8.79M0.01%−1,827−0.8%Reduced
Nicholas Investment Partners, LP243,385$9.01M0.84%+243,385New
Northern Trust Corp251,477$9.31M0.00%+1,406+0.6%Added
Morgan Stanley292,610$10.8M0.00%−22,627−7.2%Reduced
Balyasny Asset Management LLC307,314$11.4M0.04%+68,793+28.8%Added
Acuta Capital Partners, LLC365,618$13.5M6.02%+13,118+3.7%Added
Tang Capital Management LLC400,000$14.8M1.82%00.0%Unchanged
Ghost Tree Capital, LLC425,000$15.7M6.42%+175,000+70.0%Added
Deep Track Capital, LP460,861$17.1M0.84%−39,139−7.8%Reduced
Geode Capital Management, LLC490,812$18.2M0.00%−6,515−1.3%Reduced
Baker Bros. Advisors LP495,113$18.3M0.12%00.0%Unchanged
Parsons Capital Management Inc503,801$18.7M1.67%+250.0%Added
Great Point Partners LLC510,000$18.9M4.55%−190,000−27.1%Reduced
State Street Corp590,134$21.8M0.00%−11,051−1.8%Reduced
Vivo Capital, LLC713,238$26.4M2.91%+7,356+1.0%Added
Point72 Asset Management, L.P.837,190$31.0M0.13%−435,384−34.2%Reduced
Citadel Advisors LLC930,604$34.5M0.04%−16,809−1.8%Reduced
Vanguard Group Inc1,443,960$53.5M0.00%+20,928+1.5%Added
VR Adviser, LLC1,518,056$56.2M8.67%−752,016−33.1%Reduced
Ra Capital Management, L.P.2,000,000$74.0M1.58%00.0%Unchanged
BVF Inc2,078,220$76.9M3.18%+419,000+25.3%Added
BlackRock Inc.2,153,328$79.7M0.00%+4170.0%Added
Perceptive Advisors LLC2,383,478$88.2M2.56%+2,262,128+1,864.1%Added
RTW Investments, LP2,644,475$97.9M2.26%+6,894+0.3%Added
IFP Advisors, Inc2––+2New
Ally Bridge Group (NY) LLC0$00.00%−160,000−100.0%Sold out
Walleye Capital LLC0$00.00%−106,420−100.0%Sold out
Weiss Multi-Strategy Advisers LLC0$00.00%−30,000−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−12,951−100.0%Sold out
Jane Street Group, LLC0$00.00%−12,348−100.0%Sold out
Group One Trading, L.P.0$00.00%−3,354−100.0%Sold out
Captrust Financial Advisors0$00.00%−1,344−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−773−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−500−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−387−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−214−100.0%Sold out
State of Wyoming0$00.00%−42−100.0%Sold out